Not Yet Recruiting
RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas
NCT07506668
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
Not specified